<p>Vascular complications are an important and perplexing aspect of the clinical spectrum of sickle cell anemia. Patients with sickle cell disease show activation of the blood coagulation, fibrinolytic systems, increased platelet activity and consumption of coagulation inhibitors during vaso‑occlusive crises.</p>